ID   SN_HUMAN                Reviewed;        1709 AA.
AC   Q9BZZ2; Q96DL4; Q9GZS5; Q9H1H6; Q9H1H7; Q9H7L7;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Sialoadhesin;
DE   AltName: Full=Sialic acid-binding Ig-like lectin 1;
DE            Short=Siglec-1;
DE   AltName: CD_antigen=CD169;
DE   Flags: Precursor;
GN   Name=SIGLEC1; Synonyms=SN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Monocyte;
RX   PubMed=11133773; DOI=10.1182/blood.v97.1.288;
RA   Hartnell A., Steel J., Turley H., Jones M., Jackson D.G., Crocker P.R.;
RT   "Characterization of human sialoadhesin, a sialic acid binding receptor
RT   expressed by resident and inflammatory macrophage populations.";
RL   Blood 97:288-296(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 733-1709 (ISOFORMS 1 AND 2).
RC   TISSUE=Spleen;
RX   PubMed=11214971; DOI=10.1093/dnares/7.6.357;
RA   Hattori A., Okumura K., Nagase T., Kikuno R., Hirosawa M., Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen.";
RL   DNA Res. 7:357-366(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1539-1709 (ISOFORM 3).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: Acts as an endocytic receptor mediating clathrin dependent
CC       endocytosis. Macrophage-restricted adhesion molecule that mediates
CC       sialic-acid dependent binding to lymphocytes, including granulocytes,
CC       monocytes, natural killer cells, B-cells and CD8 T-cells.
CC       Preferentially binds to alpha-2,3-linked sialic acid (By similarity).
CC       Binds to SPN/CD43 on T-cells (By similarity). May play a role in
CC       hemopoiesis. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9BZZ2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BZZ2-2; Sequence=VSP_002571;
CC       Name=3;
CC         IsoId=Q9BZZ2-3; Sequence=VSP_002572;
CC   -!- TISSUE SPECIFICITY: Expressed by macrophages in various tissues. High
CC       levels are found in spleen, lymph node, perivascular macrophages in
CC       brain and lower levels in bone marrow, liver Kupffer cells and lamina
CC       propria of colon and lung. Also expressed by inflammatory macrophages
CC       in rheumatoid arthritis.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-1;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_267";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF230073; AAK00757.1; -; mRNA.
DR   EMBL; AL109804; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK024459; BAB15749.1; -; mRNA.
DR   EMBL; AK024462; BAB15752.1; -; mRNA.
DR   EMBL; AK024479; BAB15769.1; -; mRNA.
DR   EMBL; AK057560; BAB71527.1; -; mRNA.
DR   CCDS; CCDS13060.1; -. [Q9BZZ2-1]
DR   RefSeq; NP_075556.1; NM_023068.3. [Q9BZZ2-1]
DR   RefSeq; XP_006723673.1; XM_006723610.3.
DR   RefSeq; XP_011527626.1; XM_011529324.2.
DR   RefSeq; XP_011527627.1; XM_011529325.2.
DR   RefSeq; XP_011527628.1; XM_011529326.2.
DR   RefSeq; XP_011527629.1; XM_011529327.2.
DR   RefSeq; XP_011527630.1; XM_011529328.2.
DR   RefSeq; XP_011527631.1; XM_011529329.1.
DR   AlphaFoldDB; Q9BZZ2; -.
DR   SMR; Q9BZZ2; -.
DR   BioGRID; 112498; 1.
DR   STRING; 9606.ENSP00000341141; -.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   DrugBank; DB03721; N-acetyl-alpha-neuraminic acid.
DR   GlyGen; Q9BZZ2; 14 sites.
DR   iPTMnet; Q9BZZ2; -.
DR   PhosphoSitePlus; Q9BZZ2; -.
DR   BioMuta; SIGLEC1; -.
DR   DMDM; 18202745; -.
DR   jPOST; Q9BZZ2; -.
DR   MassIVE; Q9BZZ2; -.
DR   PaxDb; Q9BZZ2; -.
DR   PeptideAtlas; Q9BZZ2; -.
DR   PRIDE; Q9BZZ2; -.
DR   ProteomicsDB; 79923; -. [Q9BZZ2-1]
DR   ProteomicsDB; 79924; -. [Q9BZZ2-2]
DR   ProteomicsDB; 79925; -. [Q9BZZ2-3]
DR   Antibodypedia; 7559; 711 antibodies from 34 providers.
DR   CPTC; Q9BZZ2; 1 antibody.
DR   DNASU; 6614; -.
DR   Ensembl; ENST00000344754.6; ENSP00000341141.4; ENSG00000088827.13. [Q9BZZ2-1]
DR   GeneID; 6614; -.
DR   KEGG; hsa:6614; -.
DR   MANE-Select; ENST00000344754.6; ENSP00000341141.4; NM_023068.4; NP_075556.1.
DR   UCSC; uc002wja.3; human. [Q9BZZ2-1]
DR   CTD; 6614; -.
DR   DisGeNET; 6614; -.
DR   GeneCards; SIGLEC1; -.
DR   HGNC; HGNC:11127; SIGLEC1.
DR   HPA; ENSG00000088827; Low tissue specificity.
DR   MIM; 600751; gene.
DR   neXtProt; NX_Q9BZZ2; -.
DR   OpenTargets; ENSG00000088827; -.
DR   PharmGKB; PA35976; -.
DR   VEuPathDB; HostDB:ENSG00000088827; -.
DR   eggNOG; KOG4475; Eukaryota.
DR   GeneTree; ENSGT01040000240433; -.
DR   HOGENOM; CLU_243945_0_0_1; -.
DR   InParanoid; Q9BZZ2; -.
DR   OMA; FNSQKFE; -.
DR   OrthoDB; 54136at2759; -.
DR   PhylomeDB; Q9BZZ2; -.
DR   TreeFam; TF334827; -.
DR   PathwayCommons; Q9BZZ2; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q9BZZ2; -.
DR   BioGRID-ORCS; 6614; 17 hits in 1070 CRISPR screens.
DR   ChiTaRS; SIGLEC1; human.
DR   GenomeRNAi; 6614; -.
DR   Pharos; Q9BZZ2; Tbio.
DR   PRO; PR:Q9BZZ2; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9BZZ2; protein.
DR   Bgee; ENSG00000088827; Expressed in right adrenal gland cortex and 140 other tissues.
DR   ExpressionAtlas; Q9BZZ2; baseline and differential.
DR   Genevisible; Q9BZZ2; HS.
DR   GO; GO:0005769; C:early endosome; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0046790; F:virion binding; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB.
DR   GO; GO:0075512; P:clathrin-dependent endocytosis of virus by host cell; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; NAS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 17.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13895; Ig_2; 6.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 17.
DR   SMART; SM00408; IGc2; 14.
DR   SUPFAM; SSF48726; SSF48726; 11.
DR   PROSITE; PS50835; IG_LIKE; 14.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Disulfide bond;
KW   Endocytosis; Glycoprotein; Immunoglobulin domain; Lectin; Membrane;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000250"
FT   CHAIN           20..1709
FT                   /note="Sialoadhesin"
FT                   /id="PRO_0000014968"
FT   TOPO_DOM        20..1641
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1642..1662
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1663..1709
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..136
FT                   /note="Ig-like V-type"
FT   DOMAIN          139..233
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          238..320
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          326..405
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          411..507
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          511..593
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          601..705
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          708..785
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          799..894
FT                   /note="Ig-like C2-type 8"
FT   DOMAIN          898..977
FT                   /note="Ig-like C2-type 9"
FT   DOMAIN          984..1083
FT                   /note="Ig-like C2-type 10"
FT   DOMAIN          1085..1165
FT                   /note="Ig-like C2-type 11"
FT   DOMAIN          1176..1248
FT                   /note="Ig-like C2-type 12"
FT   DOMAIN          1259..1341
FT                   /note="Ig-like C2-type 13"
FT   DOMAIN          1350..1442
FT                   /note="Ig-like C2-type 14"
FT   DOMAIN          1445..1528
FT                   /note="Ig-like C2-type 15"
FT   DOMAIN          1536..1631
FT                   /note="Ig-like C2-type 16"
FT   BINDING         63
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250|UniProtKB:Q62230"
FT   BINDING         116
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250|UniProtKB:Q62230"
FT   BINDING         122..126
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        159
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        339
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        499
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        697
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        726
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        730
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        886
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1462
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1476
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        36..166
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        41..98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        160..217
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        262..305
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        346..390
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        433..491
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        531..575
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        624..689
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        729..774
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        817..876
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        916..960
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1005..1067
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1107..1149
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1193..1241
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1281..1324
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1367..1425
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1465..1511
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1554..1613
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1632..1709
FT                   /note="ALHRLHQFQQLLWVLGLLVGLLLLLLGLGACYTWRRRRVCKQSMGENSVEMA
FT                   FQKETTQLIDPDAATCETSTCAPPLG -> GEGRGLHLPGHSAQKPSS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214971"
FT                   /id="VSP_002571"
FT   VAR_SEQ         1666..1709
FT                   /note="RRRRVCKQSMGENSVEMAFQKETTQLIDPDAATCETSTCAPPLG -> SSLI
FT                   LMQPHVRPQPVPHPWADQWCCLPSGGESGQNL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_002572"
FT   VARIANT         141
FT                   /note="V -> L (in dbSNP:rs35953127)"
FT                   /id="VAR_049943"
FT   VARIANT         221
FT                   /note="V -> M (in dbSNP:rs6037651)"
FT                   /id="VAR_024502"
FT   VARIANT         239
FT                   /note="K -> R (in dbSNP:rs625372)"
FT                   /id="VAR_014136"
FT   VARIANT         464
FT                   /note="R -> H (in dbSNP:rs34924243)"
FT                   /id="VAR_049944"
FT   VARIANT         919
FT                   /note="H -> P (in dbSNP:rs709012)"
FT                   /id="VAR_014137"
FT   VARIANT         974
FT                   /note="A -> V (in dbSNP:rs3746638)"
FT                   /id="VAR_021926"
FT   VARIANT         1335
FT                   /note="S -> Y (in dbSNP:rs3746636)"
FT                   /id="VAR_021927"
FT   VARIANT         1487
FT                   /note="R -> W (in dbSNP:rs16988873)"
FT                   /id="VAR_049945"
FT   VARIANT         1519
FT                   /note="A -> P (in dbSNP:rs2853217)"
FT                   /id="VAR_014138"
FT   CONFLICT        1349
FT                   /note="A -> T (in Ref. 1; AAK00757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1519
FT                   /note="A -> V (in Ref. 3; BAB15749/BAB15769)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1709 AA;  182624 MW;  587C7CCA0B789A6D CRC64;
     MGFLPKLLLL ASFFPAGQAS WGVSSPQDVQ GVKGSCLLIP CIFSFPADVE VPDGITAIWY
     YDYSGQRQVV SHSADPKLVE ARFRGRTEFM GNPEHRVCNL LLKDLQPEDS GSYNFRFEIS
     EVNRWSDVKG TLVTVTEEPR VPTIASPVEL LEGTEVDFNC STPYVCLQEQ VRLQWQGQDP
     ARSVTFNSQK FEPTGVGHLE TLHMAMSWQD HGRILRCQLS VANHRAQSEI HLQVKYAPKG
     VKILLSPSGR NILPGELVTL TCQVNSSYPA VSSIKWLKDG VRLQTKTGVL HLPQAAWSDA
     GVYTCQAENG VGSLVSPPIS LHIFMAEVQV SPAGPILENQ TVTLVCNTPN EAPSDLRYSW
     YKNHVLLEDA HSHTLRLHLA TRADTGFYFC EVQNVHGSER SGPVSVVVNH PPLTPVLTAF
     LETQAGLVGI LHCSVVSEPL ATLVLSHGGH ILASTSGDSD HSPRFSGTSG PNSLRLEIRD
     LEETDSGEYK CSATNSLGNA TSTLDFHANA ARLLISPAAE VVEGQAVTLS CRSGLSPTPD
     ARFSWYLNGA LLHEGPGSSL LLPAASSTDA GSYHCRARDG HSASGPSSPA VLTVLYPPRQ
     PTFTTRLDLD AAGAGAGRRG LLLCRVDSDP PARLQLLHKD RVVATSLPSG GGCSTCGGCS
     PRMKVTKAPN LLRVEIHNPL LEEEGLYLCE ASNALGNAST SATFNGQATV LAIAPSHTLQ
     EGTEANLTCN VSREAAGSPA NFSWFRNGVL WAQGPLETVT LLPVARTDAA LYACRILTEA
     GAQLSTPVLL SVLYPPDRPK LSALLDMGQG HMALFICTVD SRPLALLALF HGEHLLATSL
     GPQVPSHGRF QAKAEANSLK LEVRELGLGD SGSYRCEATN VLGSSNTSLF FQVRGAWVQV
     SPSPELQEGQ AVVLSCQVHT GVPEGTSYRW YRDGQPLQES TSATLRFAAI TLTQAGAYHC
     QAQAPGSATT SLAAPISLHV SYAPRHVTLT TLMDTGPGRL GLLLCRVDSD PPAQLRLLHG
     DRLVASTLQG VGGPEGSSPR LHVAVAPNTL RLEIHGAMLE DEGVYICEAS NTLGQASASA
     DFDAQAVNVQ VWPGATVREG QLVNLTCLVW TTHPAQLTYT WYQDGQQRLD AHSIPLPNVT
     VRDATSYRCG VGPPGRAPRL SRPITLDVLY APRNLRLTYL LESHGGQLAL VLCTVDSRPP
     AQLALSHAGR LLASSTAASV PNTLRLELRG PQPRDEGFYS CSARSPLGQA NTSLELRLEG
     VRVILAPEAA VPEGAPITVT CADPAAHAPT LYTWYHNGRW LQEGPAASLS FLVATRAHAG
     AYSCQAQDAQ GTRSSRPAAL QVLYAPQDAV LSSFRDSRAR SMAVIQCTVD SEPPAELALS
     HDGKVLATSS GVHSLASGTG HVQVARNALR LQVQDVPAGD DTYVCTAQNL LGSISTIGRL
     QVEGARVVAE PGLDVPEGAA LNLSCRLLGG PGPVGNSTFA WFWNDRRLHA EPVPTLAFTH
     VARAQAGMYH CLAELPTGAA ASAPVMLRVL YPPKTPTMMV FVEPEGGLRG ILDCRVDSEP
     LASLTLHLGS RLVASSQPQG APAEPHIHVL ASPNALRVDI EALRPSDQGE YICSASNVLG
     SASTSTYFGV RALHRLHQFQ QLLWVLGLLV GLLLLLLGLG ACYTWRRRRV CKQSMGENSV
     EMAFQKETTQ LIDPDAATCE TSTCAPPLG
//
